Matthew W. Foehr - Apr 11, 2025 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Apr 11, 2025
Transactions value $
$166,288
Form type
4
Date filed
4/14/2025, 07:26 PM
Previous filing
Apr 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $166K +20.8K +18.68% $8.00 132K Apr 11, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -20.8K -100% $0.00 0 Apr 11, 2025 Common Stock 20.8K $8.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.